Inventor · disambiguated record
Arturo Molina
Also filed as: MOLINA ARTURO
3 granted patents·8 pending applications·13 citations·filing 2008–2023
69Inventor score
Top patents by PatentIndex Score
11 records- 0191US11160796B2Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2020·Granted Nov 2, 2021·5 cites·11 claims
- 0289US10702508B2Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2018·Granted Jul 7, 2020·6 cites·10 claims
- 0385US11491149B2Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancerARAGON PHARMACEUTICALS INC·Filed 2020·Granted Nov 8, 2022·2 cites·10 claims
- 0478US2024100033A1Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate CancerARAGON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0575US2023022446A1Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate CancerARAGON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0668US2021093620A1Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate CancerARAGON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0754US2024148890A1Anti-folate receptor conjugate therapy for cancer treatmentSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0854US2024408228A1Anti-folate receptor conjugate cancer therapySUTRO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0948US2010189716A1Treatment of hodgkins lymphomaBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 1042US2010203010A1Modulation of tumor microenvironmentBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 1141US2020207859A1Methods of using anti-cd74 antibodies and antibody conjugates in treatment of t-cell lymphomaSUTRO BIOPHARMA INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arturo Molina files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →